Sandalova S. Early Post-Marketing Safety Profile of Fezolinetant in FAERS: A Disproportionality Analysis With Emphasis on Hepatotoxicity. Int J Med Stud [Internet]. 2026 Aug. 18 [cited 2026 Aug. 28];. Available from: https://ijms.info/IJMS/article/view/4780